Alphamab Oncology Company Profile, Contacts & Intelligence
Alphamab Oncology Overview
Alphamab Oncology (Stock code: 9966.HK) is an innovative biopharmaceutical company focusing on oncology therapeutics. By leveraging its proprietary core technology platforms including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payload, dual-payload antibody conjugation, and subcutaneous high concentration formulation for biologics, the Company has established a differentiated and globally competitive product portfolio, covering cutting-edge areas such as antibody-drug conjugates (ADCs), bispecific antibodies, and single-domain antibodies. The Company has one product approved for marketing (Envafolimab, the world's first subcutaneously injectable PD-(L)1 inhibitor), which has made a significant breakthrough in the convenience and accessibility of cancer treatment. Additionally, the Company has multiple bispecific antibodies and bispecific ADCs in clinical stage, while rapidly advancing the preclinical pipeline prioritizing bispecific ADCs and dual-payload ADCs. Multiple strategic collaborations based on innovative products or technology platforms have been established with partners such as CSPC, ArriVent, and Glenmark. Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs to benefit patients.
- Headquarters
- 苏州市, 江苏省, Cn
- Website
- www.alphamabonc.com
- Industry
- Pharmaceutical Manufacturing
- Founded
- 2015
- NAICS
- Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing
Alphamab Oncology Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Alphamab Oncology People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Alphamab Oncology Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to Alphamab Oncology
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Innovent Biologics | Pharmaceutical Manufacturing | 832 | View company |
| Luye Pharma Group | Pharmaceutical Manufacturing | 750 | View company |
| Henlius | Biotechnology Research | 463 | View company |
| Biocytogen | Biotechnology Research | 193 | View company |
| Beacon | Research Services | 95 | View company |
| ArriVent Biopharma | Biotechnology Research | 67 | View company |
| MediLink Therapeutics | Biotechnology Research | 45 | View company |
| BioRay Pharmaceutical | Biotechnology Research | 38 | View company |
| AbTis | 앱티스 | Biotechnology | 16 | View company |
| Hangzhou DAC Biotech Co., Ltd. | Research | 3 | View company |